Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Roche Holding AG (GB:0QOK)
LSE:0QOK
Roche Holding AG (0QOK) Share Price & Analysis
28 Followers
0QOK Stock Chart & Stats
Day’s RangeCHF0 - CHF0
52-Week RangeCHF212.30 - CHF266.25
Previous CloseCHF243.45
Volume44.10K
Average Volume (3M)303.29K
Market Cap
CHF197.54B
Enterprise ValueCHF219.25B
Total Cash (Recent Filing)CHF7.51B
Total Debt (Recent Filing)CHF25.39B
Price to Earnings (P/E)17.0
Beta0.40
Next Earnings
Jul 25, 2024EPS Estimate
CHF9.37Last Dividend Ex-Date
Mar 14, 2024Dividend Yield4.01%
Share Statistics
EPS (TTM)14.40
Shares Outstanding702,562,700
10 Day Avg. Volume54,796
30 Day Avg. Volume303,293
Standard Deviation0.05
R-Squared0.04
Alpha0.00008
Financial Highlights & Ratios
Price to Book (P/B)93.14
Price to Sales (P/S)2.87
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF257.30Price Target Upside5.69% Upside
Rating ConsensusHold
Number of Analyst Covering12
Roche Holding AG News
Bulls Say, Bears Say
Bulls Say
EarningsThe shares are expected to continue to outperform due to substantial earnings upgrade potential driven mostly by established franchises.
Market MispricingThe stock is considered mispriced as the current share price discounts just 20 years of cash without accounting for terminal value.
Sales GrowthThree FDA approved drugs (Phesgo, Vabysmo, Hemlibra) and Diagnostics are expected to drive faster sales growth and greater operating leverage.
Bears Say
ForecastsUpgrades to the consensus forecasts are unlikely right now.
Market ConditionsManagement is emphasizing easing CV-19 and currency headwinds throughout this year.
Product PerformanceThe largest downside risks include Vabysmo and Phesgo delivering only the consensus forecasts and the group margin not expanding between 2023 and 2029.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
19.79% Mutual Funds
9.38% Other Institutional Investors
70.82% Public Companies and
Individual Investors
0QOK FAQ
What was Roche Holding AG’s price range in the past 12 months?
Roche Holding AG lowest share price was CHF212.30 and its highest was CHF266.25 in the past 12 months.
What is Roche Holding AG’s market cap?
Currently, no data Available
When is Roche Holding AG’s upcoming earnings report date?
Roche Holding AG’s upcoming earnings report date is Jul 25, 2024 which is in 18 days.
How were Roche Holding AG’s earnings last quarter?
Roche Holding AG released its earnings results on Feb 01, 2024. The company reported CHF8.47 earnings per share for the quarter, beating the consensus estimate of CHF8.37 by CHF0.1.
Is Roche Holding AG overvalued?
According to Wall Street analysts Roche Holding AG’s price is currently Undervalued.
Does Roche Holding AG pay dividends?
Roche Holding AG pays a Annually dividend of CHF9.6 which represents an annual dividend yield of 4.01%. See more information on Roche Holding AG dividends here
What is Roche Holding AG’s EPS estimate?
Roche Holding AG’s EPS estimate is CHF9.37.
How many shares outstanding does Roche Holding AG have?
Roche Holding AG has 702,562,700 shares outstanding.
What happened to Roche Holding AG’s price movement after its last earnings report?
Roche Holding AG reported an EPS of CHF8.47 in its last earnings report, beating expectations of CHF8.37. Following the earnings report the stock price went down -4.398%.
Which hedge fund is a major shareholder of Roche Holding AG?
Currently, no hedge funds are holding shares in GB:0QOK
---
Roche Holding AG Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
CHF257.30 (5.69% Upside)
CHF257.30 (5.69% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-12.08%
12-Months-Change
Fundamentals
Return on Equity
39.18%
Trailing 12-Months
Asset Growth
12.82%
Trailing 12-Months
Company Description
Roche Holding AG
Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. The Diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
---
0QOK Company Deck
---
0QOK Earnings Call
Q4 2024
0:00 / 0:00
---
0QOK Stock 12 Month Forecast
Average Price Target
CHF257.30
▲(5.69% Upside)
Technical Analysis
Best Analysts Covering 0QOK
1 Year
1 Year Success Rate
32/39 ratings generated profit
1 Year Average Return
+9.96%
reiterated a sell rating 3 days ago
Copying Richard Vosser's trades and holding each position for 1 Year would result in 82.05% of your transactions generating a profit, with an average return of +9.96% per trade.
---